GENFIT Announces 2026 Financial Calendar
(Paris:GNFT), Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 – GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial calendar for 2026. 2026 Financial Calendar February 26, 2026 Publication of revenue and cash position at December […]